Table 2.
Clinical data of the examined MS patients (N = 306).
| N (%) | Range | Median | |
|---|---|---|---|
| EDSS | 1.0–9.0 | 3.5 | |
| 1.0–3.5 | 170 (55.5) | ||
| 4.0–5.5 | 47 (15.4) | ||
| ≥6.0 | 89 (29.1) | ||
| Disease course | |||
| CIS/RRMS | 192 (62.7) | ||
| SPMS | 80 (26.1) | ||
| PPMS | 34 (11.1) | ||
| Disease duration (Years) | 0–50 | 11 | |
| 0*−5 | 88 (28.8) | ||
| 6–10 | 57 (18.6) | ||
| 11–15 | 54 (17.6) | ||
| 16–20 | 52 (17.0) | ||
| ≥21 | 55 (18.0) | ||
| Comorbidities | |||
| Pw/oSI | 109 (35.6) | ||
| PwSI | 197 (64.4) | ||
| Patient Care | |||
| Outpatients | 146 (47.7) | ||
| Inpatients | 160 (52.3) |
CIS, clinically isolated syndrome; EDSS, expanded disability status scale; MS, multiple sclerosis; N, number of patients; PPMS, primary progressive MS; PwSI, patients with secondary illnesses; Pw/oSI, patients without secondary illnesses; RRMS, relapsing-remitting MS; SPMS, secondary progressive MS.
*Six weeks as the lowest disease duration.